期刊
JACC-CARDIOVASCULAR IMAGING
卷 9, 期 11, 页码 1338-1348出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2016.09.010
关键词
cardiac MRI; diagnosis; ischemic heart disease
资金
- Bayer Pharma AG
- Siemens Healthcare
- Bayer HealthCare
- TomTec
- CVI42
- MEDIS
- Philips Healthcare
Cardiovascular magnetic resonance (CMR) has evolved from a pioneering research tool to an established noninvasive imaging method for detecting inducible myocardial perfusion deficits. In this consensus document, experts of different imaging techniques summarize the existing body of evidence regarding CMR perfusion as a viable complement to other established noninvasive tools for the assessment of perfusion and discuss the advantages and pitfalls of the technique. A rapid, standardized CMR perfusion protocol is described, which is safe, clinically feasible, and cost-effective for centers with contemporary magnetic resonance equipment. CMR perfusion can be recommended as a routine diagnostic tool to identify inducible myocardial ischemia. (C) 2016 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据